PRAX — Praxis Precision Medicines Balance Sheet
0.000.00%
- $819.64m
- $427.08m
- $8.55m
Annual balance sheet for Praxis Precision Medicines, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 297 | 276 | 100 | 81.3 | 393 |
Prepaid Expenses | |||||
Total Current Assets | 302 | 287 | 111 | 84.9 | 404 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.836 | 4.87 | 3.87 | 2.65 | 1.36 |
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 303 | 293 | 115 | 87.9 | 483 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 15.7 | 38.4 | 34.3 | 15.7 | 37.5 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 15.7 | 41.9 | 39 | 18.3 | 37.7 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 287 | 251 | 76.1 | 69.7 | 445 |
Total Liabilities & Shareholders' Equity | 303 | 293 | 115 | 87.9 | 483 |
Total Common Shares Outstanding |